SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-20-004651
Filing Date
2020-04-29
Accepted
2020-04-29 16:32:17
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A tgtx-20200429xdefa14a.htm DEFA14A 26006
2 GRAPHIC tgtx-20200429xdefa14ag001.jpg GRAPHIC 142317
3 GRAPHIC tgtx-20200429xdefa14ag002.jpg GRAPHIC 190985
4 GRAPHIC tgtx-20200429xdefa14ag003.jpg GRAPHIC 96243
5 GRAPHIC tgtx-20200429xdefa14ag004.jpg GRAPHIC 73611
  Complete submission text file 0001558370-20-004651.txt   720778
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32639 | Film No.: 20830842
SIC: 2834 Pharmaceutical Preparations